Cargando…

Esophageal Adenocarcinomas: A Need for Speed Driven by Immune Pathways That Have Druggable Targets

Detalles Bibliográficos
Autor principal:	Souza, Rhonda F.
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	Elsevier 2018
Materias:	Editorial
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5924751/ https://www.ncbi.nlm.nih.gov/pubmed/29713671 http://dx.doi.org/10.1016/j.jcmgh.2018.01.020

Ejemplares similares

Personalized medicine: exploiting druggable vulnerabilities for KRAS-driven lung cancer
por: Seguin, Laetitia, et al.
Publicado: (2018)

siRNA Library Screening Identifies a Druggable Immune-Signature Driving Esophageal Adenocarcinoma Cell Growth
por: Duggan, Shane P., et al.
Publicado: (2018)

The Tumor Microenvironment: A Druggable Target for Metastatic Disease?
por: EBioMedicine
Publicado: (2018)

FAP: Not Just a Biomarker but Druggable Target in Liver Fibrosis
por: Kim, Jieun, et al.
Publicado: (2023)

Druggable Drivers of Lung Cancer
por: Fawdar, Shameem, et al.
Publicado: (2013)

VAV2: a novel prognostic marker and a druggable target for adrenocortical carcinoma
por: Ruggiero, Carmen, et al.
Publicado: (2017)

Wild-Type KRAS Allele Effects on Druggable Targets in KRAS Mutant Lung Adenocarcinomas
por: Baldelli, Elisa, et al.
Publicado: (2021)

Data-driven analysis and druggability assessment methods to accelerate the identification of novel cancer targets
por: Beis, G., et al.
Publicado: (2022)

Targeted Therapies and Druggable Genetic Anomalies in Acute Myeloid Leukemia: From Diagnostic Tools to Therapeutic Interventions
por: Lanza, Francesco, et al.
Publicado: (2021)

Beyond finding druggable targets and tumor mutational burden: to measure heterogeneity by ctDNA
por: Liu, Zhichao, et al.
Publicado: (2020)

DRUGGABLE MM THERAPEUTICS: PATHOGENETIC PATHWAYS
por: Ocio, Enrique M
Publicado: (2022)

The Druggable Pocketome of Corynebacterium diphtheriae: A New Approach for in silico Putative Druggable Targets
por: Hassan, Syed S., et al.
Publicado: (2018)

Molecular Pathways and Druggable Targets in Head and Neck Squamous Cell Carcinoma
por: Kordbacheh, Farzaneh, et al.
Publicado: (2021)

p38α Mitogen-Activated Protein Kinase Is a Druggable Target in Pancreatic Adenocarcinoma
por: Yang, Ling, et al.
Publicado: (2019)

Mitochondrial Potassium Channels as Druggable Targets
por: Wrzosek, Antoni, et al.
Publicado: (2020)

Druggable genetic targets in endometrial cancer
por: Lehrer, Steven, et al.
Publicado: (2022)

Current and Future Treatment Strategies for Esophageal Adenocarcinoma
por: Quaas, Alexander
Publicado: (2020)

Drivers of Esophageal Adenocarcinoma and Opportunities for Cancer Interception
por: Garman, Katherine S.
Publicado: (2021)

Lessons learned in clinical epidemiology of esophageal adenocarcinoma
por: Jung, Hye Kyung
Publicado: (2022)

Targeting the COX1/2-Driven thromboxane A2 pathway suppresses Barrett's esophagus and esophageal adenocarcinoma development
por: Zhang, Tianshun, et al.
Publicado: (2019)

Identification of specific metabolic pathways as druggable targets regulating the sensitivity to cyanide poisoning
por: Sips, Patrick Y., et al.
Publicado: (2018)

Receptor tyrosine kinases as druggable targets in glioblastoma: Do signaling pathways matter?
por: Qin, Anna, et al.
Publicado: (2021)

Druggable Molecular Pathways in Chronic Lymphocytic Leukemia
por: Almasri, Mohammad, et al.
Publicado: (2022)

An integrated structural proteomics approach along the druggable genome of Corynebacterium pseudotuberculosis species for putative druggable targets
por: Radusky, Leandro G, et al.
Publicado: (2015)

Target Inhibition Networks: Predicting Selective Combinations of Druggable Targets to Block Cancer Survival Pathways
por: Tang, Jing, et al.
Publicado: (2013)

Druggable Targets of Squamous Cell Lung Cancer
por: Kim, Cheol Hyeon
Publicado: (2013)

Kinases as Druggable Targets in Trypanosomatid Protozoan Parasites
por: Merritt, Christopher, et al.
Publicado: (2014)

Network motifs modulate druggability of cellular targets
por: Wu, Fan, et al.
Publicado: (2016)

Cysteine metabolic circuitries: druggable targets in cancer
por: Bonifácio, Vasco D. B., et al.
Publicado: (2020)

Toxoplasmosis: Current and Emerging Parasite Druggable Targets
por: Hajj, Rana El, et al.
Publicado: (2021)

Novel Biomarkers and Druggable Targets in Advanced Melanoma
por: Ferrucci, Pier Francesco, et al.
Publicado: (2021)

Druggable targets and therapeutic development for COVID-19
por: Duan, Xiaohua, et al.
Publicado: (2022)

Publish or Perish: Need to have another look?
por: Jawaid, Shaukat Ali
Publicado: (2016)

Focus on Hypoxia-Related Pathways in Pediatric Osteosarcomas and Their Druggability
por: Pierrevelcin, Marina, et al.
Publicado: (2020)

A druggable copper-signalling pathway that drives inflammation
por: Solier, Stéphanie, et al.
Publicado: (2023)

Rapid COVID-19 testing: Speed, quality and cost. Can you have all three?
por: Beach, Lori A., et al.
Publicado: (2021)

SALMONELLABASE - An online database of druggable targets of Salmonella species
por: Pushpa, Ophilia Benedict, et al.
Publicado: (2012)

A new druggable target for clinical management of COPD
Publicado: (2013)

Dimeric peroxiredoxins are druggable targets in human Burkitt lymphoma
por: Trzeciecka, Anna, et al.
Publicado: (2015)

In search of druggable targets for GBM amino acid metabolism
por: Panosyan, Eduard H., et al.
Publicado: (2017)

Cannot write session to /tmp/vufind_sessions/sess_elp45hj0p5bj01birppl2fd448